Number To Know
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
PathoQuest’s NGS-based diagnostic test for infectious disease can identify 3 times more pathogens than conventional tests.
Infusion pumps, used in abundance in hospitals but prone to error, caused 710 patient deaths between 2005-2009.
Dignitana, of Lund, Sweden, is expanding the US presence of its DigniCap scalp cooling device with 9 additional installations.
Myriad Genetics’ BRACAnalysis companion diagnostic test for AstraZeneca’s PARP inhibitor, Lynparza (olaparib), demonstrated that it could identify 98% of patients with the breast cancer mutation that would best benefit from this therapy.
VisCardia gained new financing and tech assets worth $12.5m to help it advance its implantable heart failure device that works by stimulating the thoracic cavity musculature.
Q4 2016 recorded 313 medical device recalls, an 8% decrease from the previous quarter.
£9m is the amount HeartFlow's noninvasive cardiac imaging system for analyzing fractional flow reserve could save the UK NHS by 2020.
EnteroMedics' vBloc neurometabolic therapy has shown it can reduce excess weight in obese patients by an average 21%, according to recently published three-year data.
Shanghai-based MicroPort Scientific can now use its APOLLO intracranial stent to treat 5mm cerebral vessels, the longest indicated length to date, in China.
The number of medtech-related adverse-event reports in the US declined in 2016 compared to 2015.
Lombard Medical has seen 15 Japanese patients treated with its Aorfix endovascular stent graft using the latest-generation IntelliFlex LP system, which was approved in Japan a month ago and launched commercially a week ago.
Medtronic will be targeting the 800,000 Canadians affected by peripheral arterial disease after gaining Canadian approval for its IN.PACT Admiral drug-coated balloon.
You must sign in to use this functionality.
Please Sign In
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with active subscriptions will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.